Optimal timing of antimicrobial prophylaxis prior to colorectal cancer surgeryA retrospective analysis among 531 patients
- Conditions
- C18C20Malignant neoplasm of colonMalignant neoplasm of rectum
- Registration Number
- DRKS00030355
- Lead Sponsor
- niversitätsklinikum Brandenburg an der Havel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 531
Inclusion Criteria
Electronic files of people who had surgery for colorectal cancer and received cefuroxime/metronidazole, piperacillin/tazobactam, or mezlocillin/sulbactam were analyzed
Exclusion Criteria
Patients, who received neither cefuroxime/metronidazole nor piperacillin/tazobactam or mezlocillin/sulbactam were excluded.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate SSI postoperatively within 30 days
- Secondary Outcome Measures
Name Time Method Rate SSO, SSOPI postoperatively within 30 days